Phibro Animal Health (PAHC) to Release Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC) is expected to announce its earnings results after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $292.26 million for the quarter. Phibro Animal Health has set its FY 2025 guidance at 1.340-1.480 EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.35 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.12. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. The business had revenue of $260.40 million for the quarter, compared to analysts’ expectations of $277.76 million. During the same period in the prior year, the firm earned $0.14 EPS. On average, analysts expect Phibro Animal Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $21.68 on Tuesday. Phibro Animal Health has a 1-year low of $10.03 and a 1-year high of $25.98. The firm has a market capitalization of $878.04 million, a PE ratio of 50.42, a P/E/G ratio of 0.56 and a beta of 0.52. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The business’s fifty day moving average price is $21.98 and its two-hundred day moving average price is $21.56.

Analyst Ratings Changes

Several research analysts have commented on the stock. StockNews.com upgraded shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, January 29th. Morgan Stanley lifted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Finally, Barclays increased their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research report on Tuesday, November 12th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.